Post Resch Tallon Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
+175
New +$179K 0.15% 119
2026
Q1
Sell
-204
Closed -$219K 125
2025
Q4
$219K Buy
+204
New +$195K 0.19% 92

Other funds holding LLY

Post Resch Tallon Group's LLY Position: Q2 2026 in Review

Post Resch Tallon Group opened a new position in Eli Lilly (LLY) in Q2 2026: 175 shares worth $210K. The stake represents 0.15% of the portfolio and ranks #119 among its holdings. This is a return to the name: Post Resch Tallon Group previously reported a position in LLY as recently as Q4 2025.

Post Resch Tallon Group first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $219K in Q4 2025. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Post Resch Tallon Group held 175 shares of Eli Lilly worth $210K as of Q2 2026.
  • Eli Lilly was a new Post Resch Tallon Group position in Q2 2026.
  • Eli Lilly made up 0.15% of Post Resch Tallon Group's portfolio in Q2 2026, its #119 holding.
  • Post Resch Tallon Group first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Post Resch Tallon Group's Eli Lilly position peaked at $219K in Q4 2025.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Post Resch Tallon Group's 13F filing for Q2 2026, filed 7 Jul 2026.